Lentigo Maligna Melanoma ICD-10: C43.9
Often searched as: dark spot on face that keeps growing, age spot that changed, irregular brown patch on face, flat dark mark on cheek, melanoma on face elderly, growing freckle on face, sun damage spot turning into cancer, gray brown patch on skin…
Clinical urgency level
Systems Affected
Severity Levels
mild
Lentigo maligna (melanoma in situ) — still confined to the epidermis, no invasion — excellent prognosis with complete excision.
moderate
Early invasive lentigo maligna melanoma with thin Breslow depth (<1mm), no ulceration or metastasis — good prognosis with wide surgical excision ± sentinel lymph node biopsy.
severe
Deeply invasive LMM (>2mm), ulceration, lymph node involvement, or distant metastasis — requires multidisciplinary oncologic management including immunotherapy or targeted therapy.
Red Flags
- A large irregular dark brown or gray spot on the face, scalp, or neck that is slowly growing
- A previously flat pigmented patch developing a raised or nodular area within it
- Color variation within a single spot: shades of brown, black, gray, or even pink-red
- A spot with blurry, irregular, or moth-eaten borders
- Any pigmented lesion on the face of an elderly person that has been changing over months
- A spot that bleeds, ulcerates, or crusts without injury
Clinical Presentation
Lentigo maligna — large irregular pigmented patch on the cheek of an elderly patient
Source: Wikimedia Commons (CC BY-SA 3.0 )
Lentigo maligna melanoma image gallery — DermNet NZ
View gallery on DermNet NZ (image gallery reference)When to See a Doctor
See a dermatologist immediately if you have a slowly growing irregular brown or gray patch on sun-damaged skin — especially on the face, neck, or scalp of an older adult. Lentigo maligna can look deceptively like a freckle or age spot for years before becoming invasive. Early detection when still in situ is critical — it is the difference between a minor procedure and a major cancer treatment.
Differential Diagnosis
- Solar lentigo / age spot (benign — stable, uniform color)
- Seborrheic keratosis (raised, waxy — not flat)
- Pigmented actinic keratosis
- Pigmented basal cell carcinoma
- Superficial spreading melanoma
- Flat melanocytic nevus (mole)
- Post-inflammatory hyperpigmentation
Comorbidities
- Extensive actinic damage and solar lentigines (UV damage history)
- Previous melanoma or non-melanoma skin cancers
- Immunosuppression (transplant, HIV)
- Xeroderma pigmentosum
- Fair skin and history of chronic sun exposure (outdoor occupations)
Prognosis
Lentigo maligna (in situ) has a near-100% cure rate with complete surgical excision. Once it becomes invasive (lentigo maligna melanoma), prognosis depends on Breslow thickness — thin lesions (<1mm) have 5-year survival rates >95%. With lymph node involvement, survival drops to ~60%; with distant metastasis, to ~25–30% (though modern immunotherapy — nivolumab, pembrolizumab — and targeted therapy — BRAF/MEK inhibitors — have significantly improved these figures. The slow-growing nature of LMM means it is often present for years before diagnosis, making early detection campaigns critical.
Detailed Overview
Tags

Analyze your skin and hair with AI
Instantly analyze your skin with AI and get personal recommendations.
- - Get instant skin analysis
- - Personalized results from AI

* The scan result is not a diagnosis. To obtain a diagnosis and a treatment recommendation, consult your doctor.
Explore more conditions
Learn about other skin and hair conditions.